Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pau Castel

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 14, 2022
Defective protein degradation in genetic disordersPau Castel
Cell|June 25, 2021
Josep Baselga (1959-2021)Pau Castel, Eneda Toska
Cell Cycle (Georgetown, Tex.)|September 17, 2016
The emerging role of serum/glucocorticoid-regulated kinases in cancerPau Castel, Maurizio Scaltriti
Molecular & Cellular Oncology|November 7, 2019
Chromatin regulation at the intersection of estrogen receptor and PI3K pathways in breast cancerPau Castel, Eneda Toska
Nature Reviews. Cancer|April 29, 2020
The duality of human oncoproteins: drivers of cancer and congenital disordersPau Castel, Katherine A Rauen, Frank McCormick
Molecular Cell|August 14, 2024
Functional and structural insights into RAS effector proteinsAlessandro M Mozzarelli, Dhirendra K Simanshu, Pau Castel
Molecular Cell|July 18, 2024
Functional and structural insights into RAS effector proteinsAlessandro M Mozzarelli, Dhirendra K Simanshu, Pau Castel
The Biochemical Journal|August 9, 2020
The molecular functions of RIT1 and its contribution to human diseaseRichard Van, Antonio Cuevas-Navarro, Pau Castel, et al.
Nature Cancer|February 4, 2022
The present and future of PI3K inhibitors for cancer therapyPau Castel, Eneda Toska, Jeffrey A Engelman, et al.
Cancer Cell|April 30, 2021
José Baselga (1959-2021)Pau Castel, Eneda Toska, Neil Vasan, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 14, 2022
Defective protein degradation in genetic disordersPau Castel
Cell|June 25, 2021
Josep Baselga (1959-2021)Pau Castel, Eneda Toska
Cell Cycle (Georgetown, Tex.)|September 17, 2016
The emerging role of serum/glucocorticoid-regulated kinases in cancerPau Castel, Maurizio Scaltriti
Molecular & Cellular Oncology|November 7, 2019
Chromatin regulation at the intersection of estrogen receptor and PI3K pathways in breast cancerPau Castel, Eneda Toska
Nature Reviews. Cancer|April 29, 2020
The duality of human oncoproteins: drivers of cancer and congenital disordersPau Castel, Katherine A Rauen, Frank McCormick
Molecular Cell|August 14, 2024
Functional and structural insights into RAS effector proteinsAlessandro M Mozzarelli, Dhirendra K Simanshu, Pau Castel
Molecular Cell|July 18, 2024
Functional and structural insights into RAS effector proteinsAlessandro M Mozzarelli, Dhirendra K Simanshu, Pau Castel
The Biochemical Journal|August 9, 2020
The molecular functions of RIT1 and its contribution to human diseaseRichard Van, Antonio Cuevas-Navarro, Pau Castel, et al.
Nature Cancer|February 4, 2022
The present and future of PI3K inhibitors for cancer therapyPau Castel, Eneda Toska, Jeffrey A Engelman, et al.
Cancer Cell|April 30, 2021
José Baselga (1959-2021)Pau Castel, Eneda Toska, Neil Vasan, et al.
Pageof 6